Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$448,995
+$9,178 QoQ
Shares Held
18,646
+19.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#1,835
of 2,821 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SEEDS INVESTOR LLC holds $7,766,038 across 8 Drug Manufacturers - General names. PFE ranks #7 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,515 | $3,016,566 | |
| 2 | ABBV |
AbbVie Inc.
|
4,040 | $1,016,625 | |
| 3 | NVS |
Novartis AG
|
6,174 | $967,589 | |
| 4 | JNJ |
Johnson & Johnson
|
3,098 | $786,799 | |
| 5 | MRK |
Merck & Co., Inc.
|
5,502 | $707,007 | |
| 6 | AZN |
Astrazeneca PLC
|
2,548 | $483,151 | |
| 7 | PFE |
Pfizer Inc
This page
|
18,646 | $448,995 | |
| 8 | AMGN |
Amgen Inc
|
937 | $339,306 |
All Filings in PFE
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $448,995 | 18,646 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $439,817 | 15,663 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $316,479 | 12,710 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $236,862 | 9,296 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $225,310 | 9,295 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $232,038 | 9,157 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $298,807 | 11,263 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $481,272 | 16,630 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $361,165 | 12,908 | Shares | Sole | 2024-08-05 | |
| No filing history on record for this holder in this stock. | ||||||